baber/WOPTO huggingface dataset:
Patent CA-2347855-A1 (CA)
Title: Utilisation d'un agoniste du recepteur de nicotine pour le traitement de troubles obsessionnels impulsifs
Inventor: CARLSSON MARIA
IPC: A61K9/08
Filed: 1999-10-29
Abstract: L'invention concerne l'utilisation d'un agoniste du récepteur de nicotine ou d'un sel de ce dernier pharmaceutiquement acceptable pour produire une préparation pharmaceutique destinée au traitement de troubles obsessionnels impulsifs. L'invention concerne également un procédé servant au traitement d'un patient souffrant desdits troubles, qui consiste à lui administrer un agoniste du récepteur de nicotine ou un sel de ce dernier pharmaceutiquement acceptable selon une dose efficace et permettant de soulager, de réduire ou d'éliminer un ou plusieurs symptômes desdits troubles.
Patent CA-2349342-A1 (CA)
Title: Manganese compositions and methods for mri
Inventor: HARNISH PHILLIP P
IPC: A61K49/00
Filed: 1999-10-26
Abstract: An MRI contrast medium of improved safety and efficacy is disclosed. The composition includes a source of calcium ions and a source of manganese ions  in a ratio of from 2:1 to 40:1 in a vehicle suitable for parenteral administration. A method of enhancing an MRI signal in a mammalian tissue wi th the foregoing composition is also provided.
Patent CA-2349757-A1 (CA)
Title: Stripping compound for use on buildings and vessels
Inventor: LALLIER JEAN-PIERRE
IPC: C09D9/00
Filed: 2001-05-25
Abstract: A coating removing composition (I) comprising at least one dibasic ester (a), at least one dipolar aprotic solvent (b), at least one inorganic filler having a thickening effect (c), water (d), at least one activator (e), at least one dispersant (f) and at least one cellulosic thickener (g).
Patent CA-2351839-A1 (CA)
Title: Absorbent diaper pants for children with therapeutic orthopaedic pad
Inventor: MORAVEK ZDENEK
IPC: A61F5/00
Filed: 1999-02-01
Abstract: Absorbent diaper pants having a front part (2), a back part (3) with an elastic member (20) in the waist hole (12) region, and a crotch part (4) with elastic hems (19) in the diaper pants (1) leg holes (13), wherein the front part (2) and the back part (3) are provided with fastening means (21), and on the diaper pants (1) inner surface side a changeable absorbent pad (14) is arranged, and the diaper pants (1) are further provided with a therapeutic orthopaedic pad (29); characterised in that the orthopaedic pad (29) is located in a rectangular housing (27) arranged on the diaper pants (1) facing side, while this housing (27) is by its front and back transverse ends, in a takeable apart manner, secured to the end edges (9, 10) of the front part (2) and of the back part (3), and the absorbent pad (14) is inserted inside retaining means.
Patent CA-2354598-A1 (CA)
Inventor: SHIMOI HIROJI
IPC: F16H45/02
Filed: 2001-08-01
Abstract: A process for producing a friction plate having a flat friction surface includes a step of provisionally arranging a plurality of sector-shaped lining segments punched out of a friction lining tape material, in a generally annular form on an index table so as not to overlap with each other, a step of correcting the provisional arrangement of the lining segments into an annular form having no gaps between the fining segments by moving together the plurality of lining segments, provisionally arranged on the index table, towards the centre of the index table and a step of adhering the plurality of lining segments, correctly arranged in the annular form, to a surface of a core plate. A friction plate having a flat friction surface can thereby be obtained with low cost.
Patent CA-2354850-A1 (CA)
Title: Textile product made from bioactive glass fibers and its use
Inventor: HUPA MIKKO
IPC: A61K6/838
Filed: 1999-11-19
Abstract: The invention relates to a porous textile product made from bioactive glass fibers. The fibers in the product are of at least two types, fiber A and fiber B, fiber A being made from a bioactive glass, and fiber B being made from a weakly bioactive glass. This textile product is useful as an implant, as a product which yields a drug or another substance at a controlled rate, for the control of tissues, as a filler in bone cavities or soft tissue, for the removal of pulpa, as a dental root filler material, or as a binding agent for bone transplants.
Patent CA-2355037-A1 (CA)
Title: Circuit board assembly with heat sinking
Inventor: HAJICEK MICHAEL A
IPC: H05K1/02
Filed: 2001-08-14
Abstract: A circuit assembly includes a printed circuit board which has a plurality of copper traces formed thereon. Heat generating electronic components are surface mounted on the board in contact with parts of the traces. A heat conducting copper plate is mounted on the board adjacent to and spaced apart from the electronic components, and in contact with other parts of the traces. A silicon pad is mounted on the plate, and a heat sink member is mounted on the pad so that the pad is between the heat sink member and the traces. Heat conducting solder bridges are formed between the edges of the electronic components and the edges of the plate.
Patent CA-2355236-A1 (CA)
Title: Ligands and catalysts for producing elastomeric propylene polymers
Inventor: MOORE ERIC J
IPC: C07F7/08
Filed: 1999-12-14
Abstract: A ligand useful to form a metallocene olefin polymerization catalyst comprises formula (I), wherein at least R3 and R4 are substituents having at least a bulk of a t-butyl group and, optionally, wherein R1 or R2 may be a bulky substituent group.
Patent CA-2356013-A1 (CA)
Title: Flow conditioner for wet gas
Inventor: DERR CHARLES W
IPC: F15D1/02
Filed: 2001-08-28
Abstract: A flow conditioner designed for contaminated gas flow includes a number of perforations. At least one of these perforations intersects a pitch diameter on the flow conditioner that equals the diameter of the pipeline the flow conditioner is intended to be inserted in.  The provision of holes at the pipeline diameter allows the flow conditioner to pass both one-phase and contaminated flow without affecting the measurement accuracy of an associated flow meter.
Patent CA-2361824-A1 (CA)
Inventor: MCCORMICK DUANE C
IPC: F02C7/00
Filed: 2000-02-25
Abstract: The nozzle of an acoustic jet directs high momentum flux gas particles essentially tangentially into the boundary layer of the flow in a diffuser, an engine air inlet, a jet engine gas flow path or on the suction surface of an airfoil, the gas particles in the chamber of the tangential acoustic jet being replenished with approaching low momentum flux particles drawn from the gas flow in a direction normal to the surface, thereby to provide a net time-averaged flow of increased momentum flux particles to defer the onset of boundary layer separation and/or reduce the thickness of the boundary layer. The acoustic jet is driven by a gas pressure oscillation generator which may be a loudspeaker, a resonant solenoid piston, a cranked piston, or the like.
Patent CA-2362786-A1 (CA)
Inventor: SHIROMA SHIN
IPC: G06F21/10
Filed: 2000-12-15
Abstract: An information processor is connected with a terminal device to check out content to the terminal device or check in content from the terminal device.  A device driver (116) checks that a portable device (6) is connected to a personal computer (1). When the portable device (6) is connected to the personal computer (1), a start-up program (117) reads data associated with t he content from the portable device (6), and starts a display program (112) to display the associated data.
Patent CA-2363808-A1 (CA)
Inventor: SULLY DOREEN M
IPC: A21B3/13
Filed: 2001-11-27
Abstract: A utensil with a duel purpose. A press for decorating edge of crust and to protect the rim of crust from burning the first half of baking time.
Patent CA-2366778-A1 (CA)
Title: Methods for detecting nucleic acids indicative of cancer
Inventor: SHUBER ANTHONY P
IPC: C12Q1/6886
Filed: 2000-04-07
Abstract: The invention provides methods for screening tissue or body fluid samples for nucleic acid indicia of cancer or precancer.
Patent CA-2366908-A1 (CA)
Title: Composition vaccinale
Inventor: ALPAR HAZIRE OYA
IPC: A61K9/50
Filed: 2000-03-23
Abstract: L'invention concerne une composition pharmaceutique comprenant (i ) un agent biologiquement actif; (ii) un additif chimique augmentant l'effet de l'agent biologiquement actif, ce produit chimique étant sélectionné dans un ou plusieurs des éléments suivants: a) un acide polyamino, b) une vitamine ou un dérivé vitaminique, c) des pluroniques cationiques, d) un clathrate, e) un agent complexant, f) des cétrimides, g) une protéine à couche S ou h) une méthyl-glucamine; (iii) un support ou diluant pharmaceutiquement acceptable à condition que le produit chimique (ii) soit sélectionné dans d) ou e). L'agent biologiquement actif est un agent capable de générer une réponse immunitaire protectrice chez un animal auquel cette composition est administrée. La composition, sous forme de solution ou de particules telles que des microsphères ou liposomes, convient tout particulièrement à une administration par les muqueuses de vaccins, notamment par la voie intranasale ou par les voies parentérales.
Patent CA-2368146-A1 (CA)
Title: A process for the preparation of thiazolidine derivatives
Inventor: NAKAMURA NOBUYUKI
IPC: C07D277/34
Filed: 2000-03-16
Abstract: The invention relates to a process for the preparation of a thiazolidine compound of formula (I): wherein D ring is (i); wherein R is hydrogen; C1-4 alkyl, halogen or cyano; or (ii) and A is C2-6 alkylene. According to the present method, a compound of formula (I) is obtained in higher yield than t he previous method.
Patent CA-2369087-A1 (CA)
Title: Laser welding system
Inventor: KIM JEONG OH
IPC: B23K26/21
Filed: 2000-08-31
Abstract: The laser welding system comprising a welding frame for receiving a first steel plate to be welded thereupon, at least one first clamping member installed above the welding frame, for fixing the first steel plate received  on the welding frame, at least one second clamping member for fixing a secon d steel plate to be welded in close vicinity to a position at which the first steel plate is to be engaged with and welded with the second steel plate, an  anvil on which the second steel plate is received, for moving the second ste el plate to the position at which the first steel plate is to be engaged with a nd welded with the second steel plate, and a laser welding head for welding the  first and second steel plates at the position at which the first steel plate  is to be welded with the second steel plate. The first and second clamping members and the anvil are operated by air bags. The portions of the first an d second members have saw-teeth, while a portion of the anvil has saw-teeth.</ SDOAB>
Patent CA-2370859-A1 (CA)
Inventor: LAMIELLE HELENE
IPC: C08L101/14
Filed: 2000-03-23
Abstract: A refractive intraocular lens (32) including an optic portion (34) having an outer peripheral edge (36) and two opposed looped haptic elements (38). Each looped haptic element (38) is formed to have two broad connecting portions (40), two radial orientation portions (42), two spring portions (44) and a linking portion (46) for supporting the optic portion (34) in a patient's eye (10). The two broad connecting portions (40) of each looped haptic element (38) is permanently connected to the outer peripheral edge (36) of the optic portion (34). Each looped haptic element (38) is likewise formed to have greater resistance to bending in a plane generally parallel to an eye's optical axis than in a plane generally perpendicular to the eye's optical axis. The intraocular lens (32) is so designed to exhibit less than approximately 1.0 mm axial displacement or tilting of the optic portion (34) along the eye's optical axis under a compression force suitable to effect a 1.0 mm in diameter compression in overall length of the intraocular lens (32).
Patent CA-2371404-A1 (CA)
Title: Method and apparatus for the preparation of hot beverages
Inventor: MERCIER PIERRE
IPC: A47J31/00
Filed: 2002-02-12
Abstract: A method and apparatus for producing a quantity of a hot beverage, comprising providing a source of a liquid having an adjustable temperature, selecting an infusion time and an infusion temperature, supplying from the source liquid substantially at the selected infusion temperature, the supplied liquid having a volume equal to or slightly larger than the quantity, mixing the supplied liquid with a flavour ingredient having the selected infusion time and infusion temperature, infusing the flavour ingredient in the supplied liquid substantially for the selected infusion time whereby the selected ingredient is at least partially dissipated in the supplied liquid thereby forming a brew, and following the infusion time, removing an undissipated portion of the flavour ingredient from the brew thereby yielding the beverage.
Patent CA-2371739-A1 (CA)
Title: Internet control system and method
Inventor: LEWNO MARK S
IPC: H04L29/08
Filed: 2000-05-01
Abstract: A control system of the present invention includes at least one device (50), a network interconnecting (34), a control network portal (40) coupled between the network and the Internet (22), and master controller coupled (36) to the network and operable to control the operations of the Internet and the at least one device, the Internet is controllable as a device coupled to the network.
Patent CA-2372060-A1 (CA)
Inventor: BERTHIAUME RAYMOND
IPC: B23D47/04
Filed: 2002-02-14
Abstract: L'invention concerne un guide de coupe pour moulures "OGEE", ou autre pièces . Tout particulièrement l'appareil est un guide de coupe à angles complexes pour moulures et planche s de matériaux divers, profilées, ouvrées ou non.Ce guide pourra être utilisé indépendammen t, avec une scie à onglette manuelle ou électrique, un banc de scie, ou tout autres instruments  ou appareils pouvant faire la coupe de matériaux rigides tel que le bois, le plastiques et ses dérivés, les matériaux ferreux ou non, et autres. Il comprend un support pouvant être fixé à angle préderminé, servant à positionner la pièce qui doit être coupée. Ce support est rattaché à une bas e ou butoir servant à localiser le guide de coupe sur une scie à onglette manuelle ou électrique, un banc de scie, ou tout autres instruments ou appareils pouvant faire la coupe.
Patent CA-2372976-A1 (CA)
Inventor: IKEDA MASAMI
IPC: H01S5/022
Filed: 2002-02-25
Abstract: In a light source comprising a plurality of laser diode modules, high optical power is outputted, while these laser diode modules are arranged in high density. The light source is arranged by employing a plurality of laser diode modules, the optical power of which is higher than, or equal to 300 mW,
Patent CA-2374715-A1 (CA)
Title: Seamless integrated network system for wireless communication systems
Inventor: WU GANG
IPC: H04W92/14
Filed: 2002-03-06
Abstract: To create a network that connects a plurality of wireless communication systems to create optimal systems for various environments, and that seamlessly integrates the resulting systems together in order to provide more efficient and advanced service in general. A network system that can seamlessly integrate wireless communication systems employs a heterogeneous network architecture with at least four building blocks, including a mobile host 40, a wireless access network 41, a common core network 42, and an external network 43.
Patent CA-2376279-A1 (CA)
Inventor: CLERIN PHILIPPE
IPC: C01F7/473
Filed: 2000-05-29
Abstract: Procédé d'élimination de l'oxalate de sodium dans au moins une fraction (L4)  de la liqueur d'aluminate Bayer décomposée (L2) prélevée après concentration  (V) dans un cycle Bayer de production d'alumine, comportant la précipitation  de l'oxalate dissous au moyen d'un agent de destabilisation à base de chaux (C1) finement divisée puis la séparation (F) des résidus solides de désoxalatation (S4) de la liqueur (L6) recyclée comme liqueur alcaline d'attaque de la bauxite où les résidus de désoxalatation (S4) sont employés pour décarbonater et désoxalater les eaux industrielles. Le procédé devient particulièrement avantageux quand ces eaux industrielles sont des eaux brute s ou des eaux provenant d'une installation Bayer et sont dirigées après traitement vers la chaîne de lavage des résidus insolubles de la chaîne Baye r.
Patent CA-2379767-A1 (CA)
Inventor: VO HUNG-VUONG
IPC: G06F17/30
Filed: 2000-07-19
Abstract: A method and apparatus for viewing the effect of changes to an index for a database table on an optimization plan for a database query, such as an SQL  statement. A virtual table (312) is created which mimics the structure of an original table (308) on the database. The virtual table (312) is created by copying the original table (308), excluding any data in the original table.  Any existing original indexes (310) associated with original table (308) are copied to define a virtual index (314) associated with the virtual table (312). References in the query to the original table are replaced with references to the virtual table (408). The database management system then determines a new optimization plan (324) for the query.
Patent CA-2380549-A1 (CA)
Inventor: BANVILLE STEVEN C
IPC: C12Q1/68
Filed: 2000-06-01
Abstract: L'invention concerne des polynucléotides sécrétoires purifiées (SPTM), ainsi que des polypeptides (SPTM) codées par les SPTM. L'invention concerne également l'utilisation de SPTM, ou de compléments, ou d'oligonucléotides, ou de fragments de ces derniers dans des jeux ordonnés d'échantillons de diagnostic. L'invention concerne en outre des vecteurs et des cellules hôtes contenant des SPTM pour l'expression de SPTM. L'invention concerne aussi l'utilisation de SPTM isolées et purifiées pour induire des anticorps et pour examiner des bibliothèques de composés et l'utilisation d'anticorps SPTM dans des jeux ordonnés d'échantillons de diagnostic. L'invention concerne enfin des jeux ordonnés de microéchantillons contenant des SPTM et des procédés d'utilisation.
Patent CA-2386032-A1 (CA)
Inventor: WANG XIANG-YANG
IPC: C12N5/09
Filed: 2000-09-29
Abstract: Pharmaceutical compositions comprising a stress protein complex and related molecules encoding or cells presenting such a complex are provided. The stre ss protein complex comprises an hsp110 or grp170 polypeptide complexed with an immunogenic polypeptide. The immunogenic polypeptide of the stress protein complex can be associated with a cancer or an infectious disease. The pharmaceutical copmositions of the invention can be administered to a subjec t, thereby providing methods for inhibiting M. tuberculosis-infection, for inhibiting tumor growth, for inhibiting the development of a cancer, and for  the treatment or prevention of infectious disease. The invention further provides a method for producing T cells directed against a tumor cell or a M . tuberculosis-infected cell, wherein a T cell is contacted with an APC that i s modified to present an hsp110 or grp170 polypeptide and an immunogenic polypeptide associated with a tumor or with the M. tuberculosis-infected cel l. Included in the the invention are T cells produced by this method and a pharmaceutical composition comprising such T cells. The T cells can be contacted with aM. tuberculosis-infected cell in a method for killing aM. tuberculosis-infected cell, or with a tumor cell in a method for killing a tumor cell.
Patent CA-2387275-A1 (CA)
Title: Garment hanger
Inventor: SUGGITT ROBERT
IPC: A47G25/48
Filed: 2002-05-23
Abstract: A garment hanger has a spring urging a pair of clamp arms from first positions, in which the clamp arms are spaced apart from one another, towards second positions, in which the clamp arms are adjacent another; and a slide member in wedging engagement with the arms. By displacing the slide member longitudinally between the arms, the arms can be displaced from the second positions to the first positions against the action of the spring.
Patent CA-2388766-A1 (CA)
Title: Eyeglass frames based computer display or eyeglasses with operationally, actually, or computationally, transparent frames
Inventor: MANN STEVE
IPC: G02B27/00
Filed: 2002-06-17
Abstract: A wearable video or information display or fixed display or aimer is mounted in a portion of an eyeglass concealment element such as an eyeglass frame or similar structure that passes within a foveally viewable region of the wearer's field of view. The concealment element is one which is ordinarily not considered to be transparent or viewable, e.g. not ordinarily considered to be something that a wearer would look into or at or through. In some embodiments the concealment element is an eyeglass frame, because eyeglass frames are ordinarily not elements that we look through, or at, or into. The concealment element is for being present within a foveally directable portion of the wearer's field of view, so that the wearer can look directly at, into, or through the concealment member. In one embodiment the concealer is an eyeglass frame, consisting of a thin horizontal metal band that passes directly in front of the wearer's eyes. A single two-eyed eyeglass lens, or two eyeglass lenses borne by the band can be functional (for a wearer's prescription) or merely decorative, to visually justify the existence of the metal band, making it appear to take on the role of a mere physical support for the eyeglass lens(es). In another embodiment, plastic frames having viewability or transparency in some spectral band are used. In the preferred embodiment, one, two, or four eyeglass lenses are mounted to or borne by the frame in such a manner as to extend above, as well as below, the frame, so that the appearance of one or two eyeglass lenses borne above and below the central concealer (e.g. front portion of the frame) is attained.
Patent CA-2389703-A1 (CA)
Inventor: GOSSEL MATTHIAS
IPC: A61P3/04
Filed: 2000-10-21
Abstract: L'invention concerne des composés de la formule (I) dans laquelle Y désigne une liaison directe, -CH¿2?-, -CH¿2?-CH¿2? ; X désigne CH¿2?, CH(CH¿3?), CH(C¿2?H¿5?), CH(C¿3?H¿7?), CH(C¿6?H¿5?) ; R4 désigne cycloalkyle (C¿8?-C¿16?), un ou plusieurs hydrogène(s) pouvant être remplacé(s) dans les restes alkyle par du fluor ou un hydrogène pouvant être remplacé par OH, OC(O)CH¿3?, OC(O)H, O-CH¿2?-Ph ou O-alkyle (C¿1?-C¿4?) ; (CH¿2?)¿n?-A-R8, n pouvant valoir entre 1 et 6, le groupe CH¿2?-O-CH¿2?-phényle dans lequel phényle n'est pas substitué, étant excepté ; (CH¿2?)¿r?-B-R9, r pouvant valoir entre 1 et 6 ; A désigne O,S,SO,SO¿2 ?; B désigne NH,N-alkyle (C¿1?-C¿6?), NCHO, N(CO-CH¿3?) ; R8 désigne alkyle (C¿5?-C¿24?), cycloalkyle (C¿3?-C¿10?), un ou plusieurs hydrogène(s) pouvant être remplacé(s) dans les restes alkyle par fluor ou un hydrogène pouvant être remplacé par OH, OC(O)CH¿3?, OC(O)H ; O-CH¿2?-Ph ou O-alkyle (c¿1?-C¿4?) ; aryle-(CH¿2?)¿m?, m = 0 et 6 et aryle pouvant désigner phényle, naphtyle, biphényle, thiényle ou pyridyle et la part aryle pouvant être substituée jusqu'au double ; R9 désigne aryle-(CH¿2?)¿m?-aryle, m = 0 et 6 et aryle pouvant désigner phényle, naphtyle, biphényle, thiényle ou pyridyle et la part aryle pouvant être substituée jusqu'au double. Dans cette formule, les restes R¿1?, R¿'1?, R¿2? et R¿3? ont les significations mentionnées. L'invention concerne en outre les sels physiologiquement tolérables de ces composés et des procédés permettant de les préparer. Ces composés s'utilisent par ex. comme agents anorexigènes.